Longitudinal tracking of immune responses against SARS-CoV-2 can provide insight into mechanisms of immune dysfunction in COVID-19. Mathew et al. carried out deep profiling of the T cell and B cell compartments in peripheral blood of patients with COVID-19, convalescent donors and healthy controls, using high-dimensional cytometry and multiplexed cytokine analyses. By overlaying immune and clinical features, the study identifies temporal patterns in populations of activated plasmablasts, effector memory T cells and CD4+ follicular T cells. Unsupervised cluster projection identifies three ‘immunotypes’ with distinct COVID-19 severity outcomes. Notably, one subgroup has CD4+ T cell and plasmablast activation associated with severe COVID-19; another subgroup has minimal or no lymphocyte response. This study underscores the various immune trajectories in COVID-19 and may explain differences in the response to immunosuppression.
References
Original article
Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. Preprint at bioRxiv https://doi.org/10.1101/2020.05.20.106401 (2020)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Hegde, S. Many paths to COVID-19 lymphocyte dysfunction. Nat Rev Immunol 20, 408 (2020). https://doi.org/10.1038/s41577-020-0361-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-020-0361-y